Aldosterone antagonist: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz (Uses and side effects) |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
In [[pharmacology]], '''aldosterone antagonists''' are "compounds which inhibit or antagonize the biosynthesis or actions of [[aldosterone]]."<ref>{{MeSH}}</ref> | {{subpages}} | ||
In [[pharmacology]], '''aldosterone antagonists''' are "compounds which inhibit or antagonize the biosynthesis or actions of [[aldosterone]]."<ref>{{MeSH}}</ref> Their actions affect the larger [[renin-angiotensin system]]. | |||
Examples include: | Examples include: | ||
Revision as of 15:57, 24 September 2010
In pharmacology, aldosterone antagonists are "compounds which inhibit or antagonize the biosynthesis or actions of aldosterone."[1] Their actions affect the larger renin-angiotensin system.
Examples include:
- Canrenone
- Drospirenone
- Eplerenone
- Spironolactone
Uses
- Ascites
- Chronic kidney disease[2]
- Heart failure
- Hirsutism[3]
- Hypertension
- Prevention of hypokalemia caused by thiazide diuretic therapy
Side effects
References
- ↑ Anonymous (2024), Aldosterone antagonist (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF (2009). "Aldosterone antagonists for preventing the progression of chronic kidney disease.". Cochrane Database Syst Rev (3): CD007004. DOI:10.1002/14651858.CD007004.pub2. PMID 19588415. Research Blogging.
- ↑ Brown J, Farquhar C, Lee O, Toomath R, Jepson RG (2009). "Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.". Cochrane Database Syst Rev (2): CD000194. DOI:10.1002/14651858.CD000194.pub2. PMID 19370553. Research Blogging.